“[There’s] a lot going on in bladder cancer in the non–muscle invasive, muscle-invasive space, as well as in some of the biomarkers, which is exciting and will definitely have a huge impact on the ...

"We found that female patients, Black patients, and patients with non-private insurance had a decreased odds of receiving opioids,” says Hailey Frye. Researchers from the University of Minnesota, ...

"Personally, I think monitoring and analyzing PSA kinetics is a great one because it's cheap and it's readily available,” says Dr Louise Kostos. “I think that's a really good question, because I think ...

This announcement follows the successful launch of generic tiopronin delayed-release tablets last year. Tiopronin delayed-release tablets are FDA approved—in combination with high fluid intake, alkali ...

The study will evaluate the investigational drug product ONC175 (orellanine) in patients with metastatic clear cell or papillary renal cell carcinoma. The FDA has accepted an investigational new drug ...

The trial is assessing the safety and tolerability of adaptive radiation therapy with concurrent sacituzumab govitecan in patients with MIBC. In a recent interview, Laura Bukavina, MD, MPH, shared the ...

"This certainly does feel like the beginning of the light at the end of the tunnel coming out of the BCG shortage," says Chad A. Reichard, MD. The FDA recently authorized an Expanded Access Program ...

The overall prevalence of kidney stones remained stable, with a notable increase observed among women. Data published in Canadian Urologic Association Journal show that the overall prevalence of ...

An expert discusses how the SunRISe-1 phase 2b trial, presented at the European Society for Medical Oncology 2024 Congress (ESMO 2024), evaluated TAR-200 alone and with cetrelimab in BCG-unresponsive, ...

“Erectile dysfunction is a major issue that affects prostate cancer patients, but it also results in relationship issues,” explained lead author Daniel Galvão, PhD, of Edith Cowen University in ...

"4 years following radiation therapy, there is a 25% lower hazard of bowel disorders and a 46% lower hazard of related procedures [in patients who received a spacer],” says Michael R. Folkert, MD, PhD ...

35:09-41:37 Educational Outreach in OAB ...